SCHEMBL65263

SCHEMBL65263

CN(C)c1ccccc1N(C)C

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 4/20 0.55
GAA P10253 4/20 0.55
KDM4E B2RXH2 2/20 0.55
ALDH1A1 P00352 6/20 0.55
TSHR P16473 5/20 0.55
TP53 P04637 1/20 0.55
SMN1; SMN2 Q16637 1/20 0.55
CHEK1 O14757 1/20 0.52
NEK2 P51955 1/20 0.52
LIMK1 P53667 1/20 0.52
DYRK1A Q13627 1/20 0.52
CLK4 Q9HAZ1 1/20 0.52
HTR6 P50406 2/20 0.46
MAPK1 P28482 2/20 0.46
TDP1 Q9NUW8 2/20 0.46
NSD2 O96028 1/20 0.46
EGFR P00533 1/20 0.46
LMNA P02545 1/20 0.46
L3MBTL1 Q9Y468 1/20 0.46
EP300 Q09472 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18157895 0.90 MAPT (0.48) MAPTGAAKDM4EALDH1A1TSHR
SCHEMBL6236326 0.90 ALDH1A1 (0.48) MAPTGAAKDM4EALDH1A1TSHR
SCHEMBL2919461 0.83 MAPT (0.52) MAPTGAAKDM4EALDH1A1TSHR
SCHEMBL29435133 0.81 TSHR (0.50) MAPTGAAKDM4EALDH1A1TSHR
SCHEMBL29239 0.81 TSHR (0.50) MAPTGAAKDM4EALDH1A1TSHR
SCHEMBL8107644 0.81 ALDH1A1 (0.41) MAPTGAAKDM4EALDH1A1TSHR
SCHEMBL19194540 0.81 MAPT (0.41) MAPTGAAKDM4EALDH1A1TSHR
SCHEMBL10802759 0.81 CHKA (0.42) MAPTGAAKDM4EALDH1A1TSHR
SCHEMBL26418632 0.81 ALDH1A1 (0.41) MAPTGAAKDM4EALDH1A1TSHR
SCHEMBL19194548 0.81 MAPT (0.45) MAPTGAAKDM4EALDH1A1TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1240 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20260117276-A1 Frozen Biofluids Mitochondrial Bioenergetics Function Assessment Method for Traumatic Brain Injury and Polytrauma The Government of the United States, as represented by the Director of the Defense Health Agency (US) 2026-04-30 US claimed
CN-119798990-A Resin composition and use thereof 苏州生益科技有限公司 2025-04-11 CN claimed
CN-119192573-A Modified maleimide prepolymer, resin composition and application thereof 苏州生益科技有限公司 2024-12-27 CN claimed
US-20240425448-A1 METHOD FOR PRODUCING ISOCYANATE COMPOUND, METHOD FOR PRODUCING CARBAMATE COMPOUND, METHOD FOR RECOVERING AMINE COMPOUND, AND ISOCYANATE COMPOSITION ASAHI KASEI KABUSHIKI KAISHA (JP) 2024-12-26 US claimed
CN-118824098-A Hydrogel hysteromyoma model and preparation method and application thereof 浙江义在医疗科技有限公司 2024-10-22 CN claimed
EP-4431490-A1 METHOD FOR PRODUCING ISOCYANATE COMPOUNDS, METHOD FOR PRODUCING CARBAMATE COMPOUNDS, METHOD FOR RECOVERING AMINE COMPOUNDS, AND ISOCYANATE COMPOSITION Asahi Kasei Kabushiki Kaisha (JP) 2024-09-18 EP claimed
CN-115873251-B Modified maleimide prepolymer, preparation method thereof and resin composition 苏州生益科技有限公司 2024-08-06 CN claimed
WO-2024140402-A1 PREPARATION METHOD FOR MODIFIED MALEIMIDE PREPOLYMER, RESIN COMPOSITION, AND APPLICATION OF RESIN COMPOSITION 苏州生益科技有限公司 2024-07-04 WO claimed
CN-116970169-B Amine compound modified maleimide prepolymer, resin composition and application thereof 苏州生益科技有限公司 2024-06-28 CN claimed
CN-118215651-A Method for producing isocyanate compound, method for producing urethane compound, method for recovering amine compound, and isocyanate composition 旭化成株式会社 2024-06-18 CN claimed
EP-0055618-B1 CARBONYLATION PROCESS EMPLOYING A CATALYST STABILISED IN SOLUBLE FORM MONSANTO COMPANY (US) 1985-09-25 EP claimed
US-4538252-A Light induced capacitance changes in donor polymers (or small molecules) films and its use for information storage in video disks and the like INTERNATIONAL BUSINESS MACHINES CORPORATION (US) 1985-08-27 US claimed
EP-0023988-B1 USE OF A CONDUCTIVE ORGANIC CHARGE TRANSFER MATERIAL AS ELECTRON BEAM SENSITIVE RESIST COMPOSITION, AND METHOD OF FORMING POSITIVE AND NEGATIVE RESIST IMAGES International Business Machines Corporation (US) 1984-02-29 EP claimed
US-4433165-A USING N,N,N*,N*-TETRAMETHYL-O-PHENYLENEDIAMINE, OR 2,3'-DIPYRIDYL MONSANTO COMPANY (US) 1984-02-21 US claimed
EP-0073304-A1 A method of storing data in a storage device International Business Machines Corporation (US) 1983-03-09 EP claimed
EP-0055618-A1 Carbonylation process employing a catalyst stabilised in soluble form MONSANTO COMPANY (US) 1982-07-07 EP claimed
US-4338392-A Class of E-beam resists based on conducting organic charge transfer salts INTERNATIONAL BUSINESS MACHINES CORPORATION (US) 1982-07-06 US claimed
US-4312936-A Class of E-beam resists based on conducting organic charge transfer salts INTERNATIONAL BUSINESS MACHINES CORPORATION (US) 1982-01-26 US claimed
US-4312935-A Class of E-beam resists based on conducting organic charge transfer salts INTERNATIONAL BUSINESS MACHINES CORPORATION (US) 1982-01-26 US claimed
US-4076537-A Light-sensitive materials containing organo tellurium or selenium compounds and sensitizers FUJI PHOTO FILM CO., LTD. (JA) 1978-02-28 US claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260117276-A1 Frozen Biofluids Mitochondrial Bioenergetics Function Assessment Method for Traumatic Brain Injury and Polytrauma MT-CO1, MT-CO2, COX5B MAPT 370/4885GAA 1622/4885KDM4E 2200/4885
US-20240425448-A1 METHOD FOR PRODUCING ISOCYANATE COMPOUND, METHOD FOR PRODUCING CARBAMATE COMPOUND, METHOD FOR RECOVERING AMINE COMPOUND, AND ISOCYANATE COMPOSITION IDH3A, CA7, C9 MAPT 1598/4885GAA 2113/4885KDM4E 371/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.